Maravai LifeSciences Holdings Inc (NASDAQ:MRVI) price on current trading day, rose 3.19% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $1.94.
A look at the stock’s price movement, the close in the last trading session was $1.88, moving within a range at $1.74 and $2.0. The beta value (5-Year monthly) was 0.179. Turning to its 52-week performance, $11.56 and $1.78 were the 52-week high and 52-week low respectively. Overall, MRVI moved -26.52% over the past month.
Maravai LifeSciences Holdings Inc’s market cap currently stands at around $493.41 million, with investors looking forward to this quarter’s earnings report slated for on 2025-Mar-17.
Analysts have a consensus estimate of 44.01M for the company’s revenue for the quarter, with a low and high estimate of 43M and 46.8M respectively. The average forecast suggests down to a -31.43% growth in sales growth compared to quarterly growth in the same period last fiscal year. Wall Street analysts have also projected the company’s year-on-year revenue to grow to 192.75M, representing a -25.63% decline on that reported in the last financial year.
Turning to the stock’s technical picture we see that short term indicators suggest on average that MRVI is a 100% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
7 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 1 analyst(s) rate the stock as a Hold, 6 recommend MRVI as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
MRVI’s current price about -14.23% and -39.70% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 28.86, while 7-day volatility ratio is 12.69% and 9.31% in the 30-day chart. Further, Maravai LifeSciences Holdings Inc (MRVI) has a beta value of 0.27, and an average true range (ATR) of 0.24. Analysts have given the company’s stock an average 52-week price target of $5, forecast between a low of $5 and high of $5. Looking at the price targets, the low is -157.73% off current price level while to achieve the yearly target high, price needs to move -157.73%. Nonetheless, investors will most likely welcome a -157.73% jump to $5 which is the analysts’ median price.
If we refocus on Maravai LifeSciences Holdings Inc (NASDAQ:MRVI), historical trading data shows that trading volumes averaged 3.17 over the past 10 days and 3.46 million over the past 3 months. The company’s latest data on shares outstanding shows there are 141.98 million shares.
The 18.71% of Maravai LifeSciences Holdings Inc’s shares are in the hands of company insiders while institutional holders own 85.70% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 11.6 million on 2025-03-14, giving us a short ratio of 2.58. The data shows that as of 2025-03-14 short interest in Maravai LifeSciences Holdings Inc (MRVI) stood at 960.9999499999999 of shares outstanding, with shares short rising to 10.3 million registered in 2025-02-14. Current price change has pushed the stock -64.40% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the MRVI stock continues to rise going into the next quarter.
